| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cbdmd, Inc. (YCBD) has 8 insiders with recent SEC Form 4 filings, including 4 buys and 12 sells. YCBD is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 513.7K | $408.8K | - | |
| Dir | 25.1K | $20.0K | - | |
| 10% | 17.9K | $14.2K | - | |
| Dir | 12.1K | $9.6K | - | |
| Dir | 2.8K | $2.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | Crosnoe Clark R. | 10% Owner | Sell | 550,701 | $2.32 | $1,276,842.29 | -55.8% | -66.8% | - | |
| May 3, 2023 | Kennedy Thomas Ronan | Interim CEO And CFO | Buy | 5,000 | $2.10 | $10,500.00 | +342.0% | -25.9% | -54.4% | |
| Aug 24, 2021 | Kennedy Thomas Ronan | CFO &COO | Buy | 7,400 | $2.04 | $15,096.00 | New | -27.1% | -78.3% | |
| Jul 22, 2021 | Wiesehan John J III | Chief Revenue Officer | Buy | 161,550 | $0.00 | - | New | -21.4% | -82.8% | |
| Mar 11, 2021 | Sumichrast Martin A.83 | Chairman &Co-ceo | Sell | 125,000 | $3.98 | $497,681.02 | -4.1% | -24.8% | -80.9% | |
| Mar 2, 2021 | Raines William F III | Director | Sell | 20,000 | $4.04 | $80,748.00 | -93.7% | -26.0% | -79.0% | |
| Feb 22, 2021 | Coffman Raymond Scott | Co-ceo, President, Director | Sell | 125,000 | $4.25 | $531,650.70 | -50.6% | -28.6% | -82.1% | |
| Feb 19, 2021 | Sumichrast Martin A.83 | Chairman &Co-ceo | Sell | 395,600 | $4.43 | $1,753,502.96 | -40.0% | -32.1% | -80.6% | |
| Aug 14, 2020 | Sellers Bakari T. | Director | Sell | 10,000 | $3.43 | $34,300.00 | -79.8% | - | - | |
| Mar 9, 2020 | Ghiloni Peter J. | Director | Buy | 25,000 | $0.75 | $18,720.00 | +9.1% | - | - |